What Are CJC-1295 & Ipamorelin?
The GHRH + GHRP research pairing explained.
Home › Compound guides › Tesamorelin
A stabilized GHRH analog studied for its effect on growth-hormone signalling — what it is, how it works, and how it’s handled.
Tesamorelin sits in the same broad family as CJC-1295 — it’s a growth-hormone-releasing hormone analog. What sets it apart is stability: it’s a modified form of GHRH built to hold up better than the natural hormone.
Tesamorelin is a stabilized synthetic analog of GHRH (growth-hormone-releasing hormone). By mimicking GHRH, it is studied for how it prompts the pituitary to release growth hormone. Note that tesamorelin has a narrow approved clinical use for a specific medical condition; on this site it is discussed only as a research compound and supplied for research use only.
GHRH is the body’s natural trigger for growth-hormone release. As a GHRH analog, tesamorelin engages that same GHRH pathway at the pituitary. Because it’s a stabilized version, it’s of research interest for acting on that pathway in a more durable form than native GHRH.
The GH-releasing peptides split by which signal they use. Tesamorelin and CJC-1295 are both GHRH analogs; ipamorelin works on a different receptor entirely.
| Peptide | Class | Pathway |
|---|---|---|
| Tesamorelin | GHRH analog | GHRH receptor |
| CJC-1295 | GHRH analog | GHRH receptor |
| Ipamorelin | GHRP | Ghrelin receptor |
Like most research peptides, tesamorelin arrives as a lyophilized (freeze-dried) powder. Before it can be used in solution it has to be reconstituted:
With an investigational peptide, knowing exactly what is in the vial is everything. A reputable source provides a Certificate of Analysis (COA) showing third-party HPLC purity and mass-spec identity for that specific batch. If you are not sure how to read one, see what is a COA.
We recommend Vital Chems for tested compounds and bacteriostatic water.